INTEGRA LIFESCIENCES HOLDINGS CORP (IART)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 600M 1.2B 1.8B Q3 '24: 1.6B Q4 '24: 1.6B Q1 '25: 1.6B Q2 '25: 1.6B Q3 '25: 1.6B Q4 '25: 1.6B Q1 '26: 1.6B Q2 '26: 1.6B Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit TTM

0 350M 700M 1.1B Q1 '19: 918.9M Q2 '19: 930.2M Q3 '19: 944.1M Q4 '19: 952.9M Q1 '20: 942.9M Q2 '20: 856.2M Q3 '20: 855.1M Q4 '20: 851M Q1 '19 Q2 '19 Q3 '19 Q4 '19 Q1 '20 Q2 '20 Q3 '20 Q4 '20

Operating Income TTM

-600M -400M -200M 0 200M 400M 600M Q3 '24: 28.8M Q4 '24: 28.4M Q1 '25: 9M Q2 '25: -500.7M Q3 '25: -480.8M Q4 '25: -493.4M Q1 '26: -466.4M Q2 '26: 65.6M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income TTM

-600M -400M -200M 0 200M 400M 600M Q3 '24: -6.5M Q4 '24: -6.9M Q1 '25: -29M Q2 '25: -500.6M Q3 '25: -495.3M Q4 '25: -516.5M Q1 '26: -495.8M Q2 '26: -7.2M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue TTM

0 300M 600M 900M Q3 '24: 705.4M Q4 '24: 728.5M Q1 '25: 754.6M Q2 '25: 768.7M Q3 '25: 783.1M Q4 '25: 803.6M Q1 '26: 790.3M Q2 '26: 783.1M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow TTM

0 50M 100M 150M Q3 '24: 137.4M Q4 '24: 129.4M Q1 '25: 102.4M Q2 '25: 70.9M Q3 '25: 89.3M Q4 '25: 50.4M Q1 '26: 71.4M Q2 '26: 85.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow TTM

-45M -30M -15M 0 15M 30M 45M Q3 '24: 38M Q4 '24: 25M Q1 '25: -15.5M Q2 '25: -37.4M Q3 '25: -4.5M Q4 '25: -31.1M Q1 '26: 4.1M Q2 '26: 25.8M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 30M 60M 90M Q1 '24: 77.7M Q2 '24: 77.4M Q3 '24: 76.4M Q1 '25: 76.5M Q2 '25: 76.7M Q3 '25: 76.8M Q1 '26: 77M Q2 '26: 78.2M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q3 '24: -0.09 Q4 '24: -0.09 Q1 '25: -0.38 Q2 '25: -6.53 Q3 '25: -6.46 Q4 '25: -6.73 Q1 '26: -6.46 Q2 '26: -0.09 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.